Page 31 - Ppd Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thermo Fisher To Buy PPD In $17.4 Bln Cash Deal WASHINGTON (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO) and clinical research organization PPD, Inc. (PPD) announced Thursday that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share for a total cash purchase price of $17.4 billion, plus the assumption of about $3.5 billion of net debt. The per share consideration represents a premium of approximately 24 percent to the unaffected closing price of PPD's common stock on the Nasdaq as of Tuesday, April 13, 2021. PPD provi...

Medable, Inc., a Palo Alto, Calif.-based provider of a digital platform to decentralize clinical trials, raised $78m in funding. The round was led by Sapphire Ventures, with participation from new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc. (Nasdaq:PPD) and Streamlined Ventures. The company, which has raised more than $217m to date, intends to use the funds to continue enabling broad adoption of digital trials and patient-centric strategies at global scale. Key focus areas include internal initiatives related to ubiquitous resear...

WeissLaw LLP is investigating whether PPD's board acted in the best interest of PPD's public shareholders in agreeing to the proposed transaction and whether all information regarding the process undertaken by the board and the valuation of the transaction will be fully and fairly disclosed to PPD's public shareholders.  WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If ...

Thermo Fisher to acquire CRO firm PPD for $17.4 B Thermo Fisher to acquire CRO firm PPD for $17.4 B 15 April 2021 | News Image credit- shutterstock.com Thermo Fisher Scientific Inc. and PPD, Inc. have announced that their boards of directors have approved a definitive agreement under which Thermo Fisher will acquire PPD for $47.50 per share for a total cash purchase price of $17.4 billion plus the assumption of approximately $3.5 billion of net debt. This represents a premium of approximately 24% to the unaffected closing price of PPD's common stock on the Nasdaq as of Tuesday, Apri...

What You Should Know: – Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc., and Streamlined Ventures. – This is Medable’s third round of funding in less than a year, bringing total capital raised to more th...